Abstract:Extracellular vesicles (EVs) have emerged as important carriers for intercellular communication and biological sources for diagnosis and therapeutics. Low efficiency in EV isolation from biofluids, however, severely restricts their downstream characterization and analysis. Here, we introduced a novel strategy for EV isolation from urine for prostate cancer diagnosis using bifunctionalized magnetic beads through high affinity Ti(IV) ions and the insertion of a phospholipid derivative, 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine, into the EV membrane synergistically. We demonstrated its efficient isolation of EVs from urine samples with low contamination, high recovery (>80%), and short separation time (within 1 h), resulting in the identification of 36,262 unique EV peptides corresponding to 3302 unique proteins and 3233 unique phosphopeptides representing 1098 unique phosphoproteins using only 100 μL and 5 mL urine samples, respectively. Coupled with trapped ion mobility spectrometry and parallel accumulation–serial fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics of urine samples from prostate cancer patients and healthy individuals revealed 121 upregulated phosphoproteins in cancer patients in contrast to the healthy group. These particular advantages indicate that the novel bifunctional material enables sensitive EV phosphoproteomic analysis for noninvasive biomarker screening and early cancer diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19400</a>.FTIR, zeta potential, and fluorescence characterization of the different MBs-based materials (Figure S1); size distribution characterization of EVs isolated using UC, TiMBs, and DspeMBs (Figure S2); whole proteome overlap among different methods and top proteins of exosome and the phosphopeptides analysis of different isolation methods (Figure S3); Pearson correlation of EV proteomes of the clinical urine samples (Figure S4); the interaction pathway of the upregulated phosphoproteins (Figure S5); fold increase in these 13 exosomal proteins and 3 free urine proteins from LC–MS data of different methods compared to the UC sample (Table S2); and the list of the cancer-associated upregulated phosphoproteins (Table S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_001.pdf">PDF</a>)LC–MS whole proteome analysis data of EVs isolated by different methods (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_002.xlsx">XLSX</a>)LC–MS phosphoproteome analysis data of EVs isolated by different methods (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_003.xlsx">XLSX</a>)LC–MS prostate cancer-specific EV phosphoproteins analysis data (Table S4) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_004.xlsx">XLSX</a>)Mobility resolution of phosphorylation site isomers in urine EVs from prostate cancer patients (Table S6) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_005.xlsx">XLSX</a>)This article has not yet been cited by other publications.

One-Pot Sequential Enrichment of Urinary Extracellular Vesicle and miRNAs Identifies a Noninvasive Biomarker Panel for Prostate Cancer Diagnosis

High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer

An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis

Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics

Rapid Enrichment and Sensitive Detection of Extracellular Vesicles Through Measuring the Phospholipids and Transmembrane Protein in a Microfluidic Chip.

Nanomaterials-Based Urinary Extracellular Vesicles Isolation and Detection for Non-invasive Auxiliary Diagnosis of Prostate Cancer

Diagnosis of Prostate Cancer through the Multi-Ligand Binding of Prostate-Derived Extracellular Vesicles and miRNA Analysis

Applications of Urinary Extracellular Vesicles in the Diagnosis and Active Surveillance of Prostate Cancer

Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers

An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer

Diagnostic Plasma Small Extracellular Vesicles Mirna Signatures for Pancreatic Cancer Using Machine Learning Methods

Tumor-derived extracellular vesicle nucleic acids as promising diagnostic biomarkers for prostate cancer

Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis

Harnessing microRNA-enriched extracellular vesicles for liquid biopsy

One‐Step Thermophoretic AND Gate Operation on Extracellular Vesicles Improves Diagnosis of Prostate Cancer

Optimising Extracellular Vesicle Metabolomic Methodology for Prostate Cancer Biomarker Discovery

Simultaneous detection of membrane protein and mRNA at single extracellular vesicle level by droplet microfluidics for cancer diagnosis

Emerging Sensing and In Situ Detection Technologies for the Analysis of Extracellular Vesicle miRNAs

Colocalization of protein and microRNA markers reveals unique extracellular vesicle subpopulations for early cancer detection

Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice